» Articles » PMID: 33864904

Combinatorial Lipid-nanosystem for Dermal Delivery of 5-fluorouracil and Resveratrol Against Skin Cancer: Delineation of Improved Dermatokinetics and Epidermal Drug Deposition Enhancement Analysis

Overview
Specialty Pharmacology
Date 2021 Apr 17
PMID 33864904
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, combinatorial nanostructured lipid carrier gel of 5-fluorouracil and resveratrol was formulated, optimized and characterized to enhance permeation in between epidermis and dermis layers of the skin to obtain a synergistic effect against skin cancer. After extensive trials, a newly modified emulsiosonication method was developed and additionally, for the first time, stability studies were done in the beginning to optimize formulation technique, which exhibited two major benefits simultaneously; first, it provided best-optimized technique for preparation of combinatorial lipid-nanosystem, and secondly, it also demonstrated a detailed report card of durability of formulations. In vitro release study showed a significantly improved, slow and prolonged release of drugs from the optimized lipid-nanosystem (***p < 0.05), which followed non-Fickian Higuchi kinetics. Besides, mechanism of skin permeation enhancement study, dermatokinetic assessment, and depth analysis of optimized formulation on skin exhibited improved permeation and well distribution of drugs up to the dermis layer of skin. Moreover, combinatorial linogel possessed significantly greater efficacy (**p < 0.01) on the A431 cell line, as compared to the conventional formulation. Thus, findings revealed that modified method of preparation for dual drug-loaded lipid-nanosystem lead to the production of a stable formulation that also improved the retention of both 5-fluorouracil and resveratrol in between the epidermis and dermis region of skin thereby helping in the management and treatment of skin cancer.

Citing Articles

5-Fluorouracil- and Sesamol-Loaded Transliposomal Gel for Skin Cancer: , and Dermatokinetic Evaluation.

Jahan S, Sultana N, Ali A, Emad N, Alam P, Mujeeb M ACS Omega. 2025; 10(7):6857-6875.

PMID: 40028080 PMC: 11865969. DOI: 10.1021/acsomega.4c09147.


Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications.

Salazar J, Ortega A, Perez J, Garrido B, Santeliz R, Galban N Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006060 PMC: 11859979. DOI: 10.3390/ph18020247.


Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms.

Singaravelan N, Tollefsbol T Nutrients. 2025; 17(4).

PMID: 40004944 PMC: 11858336. DOI: 10.3390/nu17040616.


Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.

Abid F, Kim S, Savaliya B, Cesari L, Amirmostofian M, Abdella S Int J Nanomedicine. 2025; 20:2181-2204.

PMID: 39990290 PMC: 11847435. DOI: 10.2147/IJN.S497108.


Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review.

Zamanian M, Shahbazi T, Kazmi S, Hussien B, Sharma A, Qasim M Food Sci Nutr. 2024; 12(11):8825-8845.

PMID: 39620024 PMC: 11606877. DOI: 10.1002/fsn3.4555.